Hugo R. Rosen - Publications

Affiliations: 
Immunology University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Immunology, Microbiology Biology, Virology Biology

224 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Valencia A, Vergara C, Thio CL, Vince N, Douillard V, Grifoni A, Cox AL, Johnson EO, Kral AH, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, ... ... Rosen HR, et al. Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1. American Journal of Human Genetics. PMID 35090584 DOI: 10.1016/j.ajhg.2022.01.001  0.399
2021 Burchill MA, Salomon MP, Golden-Mason L, Wieland A, Maretti-Mira AC, Gale M, Rosen HR. Single-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes. Plos Pathogens. 17: e1009799. PMID 34370798 DOI: 10.1371/journal.ppat.1009799  0.4
2020 Setiawan VW, Rosen HR. Stratification of residual risk of hepatocellular carcinoma following HCV clearance with DAA in patients with advanced fibrosis and cirrhosis. Hepatology (Baltimore, Md.). PMID 33205438 DOI: 10.1002/hep.31639  0.425
2020 Vergara C, Valencia A, Thio CL, Goedert JJ, Mangia A, Piazzolla V, Johnson E, Kral AH, O'Brien TR, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, ... ... Rosen HR, et al. A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus. The Journal of Infectious Diseases. PMID 33119750 DOI: 10.1093/infdis/jiaa677  0.433
2020 Burchill MA, Finlon JM, Goldberg AR, Gillen AE, Dahms PA, McMahan RH, Tye A, Winter AB, Reisz JA, Bohrnsen E, Schafer JB, D'Alessandro A, Orlicky DJ, Kriss MS, Rosen HR, et al. Oxidized Low-Density Lipoprotein drives dysfunction of the liver lymphatic system. Cellular and Molecular Gastroenterology and Hepatology. PMID 32961356 DOI: 10.1016/J.Jcmgh.2020.09.007  0.371
2020 Kriss M, Golden-Mason L, Kaplan J, Mirshahi F, Setiawan VW, Sanyal AJ, Rosen HR. Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development. Plos One. 15: e0236353. PMID 32730345 DOI: 10.1371/Journal.Pone.0236353  0.399
2020 Hernaez R, Patel A, Jackson LK, Braun UK, Walling AM, Rosen HR. Considerations for prognosis, goals of care, and specialty palliative care for hospitalized patients with acute-on-chronic liver failure. Hepatology (Baltimore, Md.). PMID 32416642 DOI: 10.1002/Hep.31316  0.357
2020 Kriss MS, Burton JR, Rosen HR. Biological Principles and Clinical Issues Underlying Liver Transplantation for Viral‐Induced End‐Stage Liver Disease in the Era of Highly Effective Direct‐Acting Antiviral Agents Liver. 926-934. DOI: 10.1002/9781119436812.Ch69  0.4
2019 Rosen HR, Golden-Mason L. Control of HCV Infection by Natural Killer Cells and Macrophages. Cold Spring Harbor Perspectives in Medicine. PMID 31871225 DOI: 10.1101/Cshperspect.A037101  0.54
2019 Noureddin M, Zelber-Sagi S, Wilkens LR, Porcel J, Boushey CJ, Le Marchand L, Rosen HR, Setiawan VW. Diet associations with nonalcoholic fatty liver disease in an ethnically diverse population: the Multiethnic Cohort. Hepatology (Baltimore, Md.). PMID 31553803 DOI: 10.1002/Hep.30967  0.316
2019 Tamburini BAJ, Finlon JM, Gillen AE, Kriss MS, Riemondy KA, Fu R, Schuyler RP, Hesselberth JR, Rosen HR, Burchill MA. Chronic Liver Disease in Humans Causes Expansion and Differentiation of Liver Lymphatic Endothelial Cells. Frontiers in Immunology. 10: 1036. PMID 31156626 DOI: 10.3389/Fimmu.2019.01036  0.425
2018 Vergara C, Thio CL, Johnson E, Kral AH, O'Brien TR, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, Peters MG, ... ... Rosen HR, et al. Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. Gastroenterology. PMID 30593799 DOI: 10.1053/J.Gastro.2018.12.014  0.544
2018 McGettigan B, McMahan R, Orlicky D, Burchill M, Danhorn T, Francis P, Cheng LL, Golden-Mason L, Jakubzick C, Rosen H. Dietary Lipids Differentially Shape NASH Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages. Hepatology (Baltimore, Md.). PMID 30516830 DOI: 10.1002/Hep.30401  0.378
2018 Kriss M, Verna EC, Rosen HR, Lozupone CA. Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes. Transplantation. PMID 30507741 DOI: 10.1097/Tp.0000000000002568  0.389
2018 Golden-Mason L, Rosen HR. Revisiting the Paradox of ISG expression as a predictor of HCV treatment response, a decade later. Hepatology (Baltimore, Md.). PMID 30055107 DOI: 10.1002/Hep.30195  0.465
2018 Golden-Mason L, McMahan RH, Kriss MS, Kilgore AL, Cheng L, Dran RJ, Wieland A, Rosen HR. Early and late changes in natural killer cells in response to ledipasvir/sofosbuvir treatment. Hepatology Communications. 2: 364-375. PMID 29619416 DOI: 10.1002/hep4.1166  0.424
2018 Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, Nakagawa T, Kuwabara M, Sato Y, Kang DH, Tolan DR, Sanchez-Lozada LG, Rosen HR, Lanaspa MA, Diehl AM, et al. Fructose and Sugar: A Major Mediator of Nonalcoholic Fatty Liver Disease. Journal of Hepatology. PMID 29408694 DOI: 10.1016/J.Jhep.2018.01.019  0.383
2018 Kilgore AL, Fennimore B, Shearn C, Williams S, McMahan R, Rosen H, Golden-Mason L. Mo1467 - Hepatic Natural Killer Cell Gender Differences in the Pathogenesis of Cholestatic Liver Disease Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)34015-0  0.479
2017 Huang H, Duggal P, Thio CL, Latanich R, Goedert JJ, Mangia A, Cox AL, Kirk GD, Mehta S, Aneja J, Alric L, Donfield SM, Cramp ME, Khakoo SI, Tobler LH, ... ... Rosen HR, et al. Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection. Scientific Reports. 7: 15843. PMID 29158528 DOI: 10.1038/S41598-017-16011-2  0.495
2017 Burchill MA, Roby JA, Crochet N, Wind-Rotolo M, Stone AE, Edwards MG, Dran RJ, Kriss MS, Gale M, Rosen HR. Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy. Plos One. 12: e0186213. PMID 29040318 DOI: 10.1371/Journal.Pone.0186213  0.787
2017 Rosen E, Bakshi N, Watters A, Rosen HR, Mehler PS. Hepatic Complications of Anorexia Nervosa. Digestive Diseases and Sciences. PMID 28932925 DOI: 10.1007/S10620-017-4766-9  0.475
2017 Cobb DA, Golden-Mason L, Rosen HR, Hahn YS. Hepatocyte-derived exosomes promote T follicular regulatory cell expansion during HCV infection. Hepatology (Baltimore, Md.). PMID 28749570 DOI: 10.1002/Hep.29409  0.584
2017 Wang Y, Singh NK, Spear TT, Hellman LM, Piepenbrink KH, McMahan RH, Rosen HR, Vander Kooi CW, Nishimura MI, Baker BM. How an alloreactive T-cell receptor achieves peptide and MHC specificity. Proceedings of the National Academy of Sciences of the United States of America. PMID 28572406 DOI: 10.1073/Pnas.1700459114  0.477
2017 Golden-Mason L, Rosen HR. Galectin-9: Diverse Roles in Hepatic Immune Homeostasis and Inflammation. Hepatology (Baltimore, Md.). PMID 28195343 DOI: 10.1002/Hep.29106  0.483
2017 Giugliano S, Petroff MG, Warren BD, Jasti S, Linscheid C, Ward A, Kramer A, Dobrinskikh E, Sheiko MA, Gale M, Golden-Mason L, Winn VD, Rosen HR. Correction: Hepatitis C Virus Sensing by Human Trophoblasts Induces Innate Immune Responses and Recruitment of Maternal NK Cells: Potential Implications for Limiting Vertical Transmission. Journal of Immunology (Baltimore, Md. : 1950). 198: 972. PMID 28069758 DOI: 10.4049/jimmunol.1601926  0.345
2016 Kalra A, Wedd JP, Bambha KM, Gralla J, Golden-Mason L, Collins C, Rosen HR, Biggins SW. Neutrophil-to-Lymphocyte Ratio Correlates with Proinflammatory Neutrophils and Predicts Death in Low MELD Cirrhotic Patients. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 28006875 DOI: 10.1002/Lt.24702  0.354
2016 Rosen HR. "Hep C, where art thou": What are the remaining (fundable) questions in HCV research? Hepatology (Baltimore, Md.). PMID 27640881 DOI: 10.1002/Hep.28848  0.542
2016 McGettigan BM, McMahan RH, Luo Y, Wang XX, Orlicky DJ, Porsche C, Levi M, Rosen HR. Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-Alcoholic Fatty Liver Disease. The Journal of Biological Chemistry. PMID 27605663 DOI: 10.1074/Jbc.M116.731042  0.343
2016 McMahan RH, Porsche CE, Edwards MG, Rosen HR. Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease. Plos One. 11: e0159217. PMID 27454769 DOI: 10.1371/Journal.Pone.0159217  0.364
2016 White JT, Cross EW, Burchill MA, Danhorn T, McCarter MD, Rosen HR, O'Connor B, Kedl RM. Virtual memory T cells develop and mediate bystander protective immunity in an IL-15-dependent manner. Nature Communications. 7: 11291. PMID 27097762 DOI: 10.1038/Ncomms11291  0.313
2016 Spear TT, Riley TP, Lyons GE, Callender GG, Roszkowski JJ, Wang Y, Simms PE, Scurti GM, Foley KC, Murray DC, Hellman LM, McMahan RH, Iwashima M, Garrett-Mayer E, Rosen HR, et al. Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability. Journal of Leukocyte Biology. PMID 26921345 DOI: 10.1189/Jlb.2A1215-561R  0.375
2016 Goh CC, Roggerson KM, Lee HC, Golden-Mason L, Rosen HR, Hahn YS. Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1. Journal of Immunology (Baltimore, Md. : 1950). PMID 26826241 DOI: 10.4049/Jimmunol.1501881  0.577
2015 Sheiko MA, Golden-Mason L, Giugliano S, Hurtado CW, Mack CL, Narkewicz MR, Rosen HR. CD4(+) and CD8(+) T Cell Activation in Children with Hepatitis C. The Journal of Pediatrics. PMID 26743497 DOI: 10.1016/J.Jpeds.2015.11.055  0.48
2015 Nordstrom EM, Biggins SW, Gralla J, Rosen HR, Everson GT, Burton JR. Consensus Interferon for Recurrent Hepatitis C Infection in Nonresponders to Peginterferon and Ribavirin After Liver Transplant. Experimental and Clinical Transplantation : Official Journal of the Middle East Society For Organ Transplantation. 13: 543-9. PMID 26643674 DOI: 10.6002/ect.2015.0061  0.492
2015 Rosen HR, Golden-Mason L, Daly AK, Yang I, Day CP. Variants in the LGALS9 Gene are Associated with Development of Liver Disease in Heavy Consumers of Alcohol. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 26598225 DOI: 10.1016/J.Cgh.2015.11.005  0.339
2015 Rosen HR, Biggins SW, Niki T, Gralla J, Hillman H, Hirashima M, Schilsky M, Lee WM. Association Between Plasma Level of Galectin-9 and Survival of Patients With Drug-Induced Acute Liver Failure. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 26499927 DOI: 10.1016/J.Cgh.2015.09.040  0.4
2015 Burchill MA, Golden-Mason L, Wind-Rotolo M, Rosen HR. Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals. Journal of Viral Hepatitis. 22: 983-91. PMID 26482547 DOI: 10.1111/Jvh.12465  0.546
2015 Harwood NM, Golden-Mason L, Cheng L, Rosen HR, Mengshol JA. HCV-infected cells and differentiation increase monocyte immunoregulatory galectin-9 production. Journal of Leukocyte Biology. PMID 26475932 DOI: 10.1189/Jlb.5A1214-582R  0.537
2015 Giugliano S, Petroff MG, Warren BD, Jasti S, Linscheid C, Ward A, Kramer A, Dobrinskikh E, Sheiko MA, Gale M, Golden-Mason L, Winn VD, Rosen HR. Hepatitis C Virus Sensing by Human Trophoblasts Induces Innate Immune Responses and Recruitment of Maternal NK Cells: Potential Implications for Limiting Vertical Transmission. Journal of Immunology (Baltimore, Md. : 1950). 195: 3737-47. PMID 26342030 DOI: 10.4049/Jimmunol.1500409  0.546
2015 Dirchwolf M, Dodge JL, Gralla J, Bambha KM, Nydam T, Hung KW, Rosen HR, Feng S, Terrault NA, Biggins SW. The corrected donor age for hepatitis C virus infected liver transplant recipients. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 26074140 DOI: 10.1002/Lt.24194  0.487
2015 Hung K, Gralla J, Dodge JL, Bambha KM, Dirchwolf M, Rosen H, Biggins SW. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 25865434 DOI: 10.1002/Lt.24138  0.468
2015 Golden-Mason L, Waasdorp Hurtado CE, Cheng L, Rosen HR. Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3. Clinical Immunology (Orlando, Fla.). 158: 114-25. PMID 25797693 DOI: 10.1016/J.Clim.2015.03.008  0.51
2015 Mitchell AM, Stone AE, Cheng L, Ballinger K, Edwards MG, Stoddard M, Li H, Golden-Mason L, Shaw GM, Khetani S, Rosen HR. Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver. Mbio. 6: e02510. PMID 25714713 DOI: 10.1128/Mbio.02510-14  0.799
2015 Giugliano S, Kriss M, Golden-Mason L, Dobrinskikh E, Stone AE, Soto-Gutierrez A, Mitchell A, Khetani SR, Yamane D, Stoddard M, Li H, Shaw GM, Edwards MG, Lemon SM, Gale M, ... ... Rosen HR, et al. Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication. Gastroenterology. 148: 392-402.e13. PMID 25447848 DOI: 10.1053/J.Gastro.2014.10.040  0.798
2014 Biggins SW, Gralla J, Dodge JL, Bambha KM, Tong S, Barón AE, Inadomi J, Terrault N, Rosen HR. Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 14: 2588-94. PMID 25243648 DOI: 10.1111/Ajt.12867  0.564
2014 Golden-Mason L, Hahn YS, Strong M, Cheng L, Rosen HR. Extracellular HCV-core protein induces an immature regulatory phenotype in NK cells: implications for outcome of acute infection. Plos One. 9: e103219. PMID 25076408 DOI: 10.1371/Journal.Pone.0103219  0.54
2014 Stone AE, Mitchell A, Brownell J, Miklin DJ, Golden-Mason L, Polyak SJ, Gale MJ, Rosen HR. Hepatitis C virus core protein inhibits interferon production by a human plasmacytoid dendritic cell line and dysregulates interferon regulatory factor-7 and signal transducer and activator of transcription (STAT) 1 protein expression. Plos One. 9: e95627. PMID 24788809 DOI: 10.1371/Journal.Pone.0095627  0.76
2013 Rosen HR. Emerging concepts in immunity to hepatitis C virus infection. The Journal of Clinical Investigation. 123: 4121-30. PMID 24084744 DOI: 10.1172/Jci67714  0.536
2013 Golden-Mason L, Rosen HR. Natural killer cells: multifaceted players with key roles in hepatitis C immunity. Immunological Reviews. 255: 68-81. PMID 23947348 DOI: 10.1111/Imr.12090  0.581
2013 Ishimoto T, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Orlicky DJ, Cicerchi C, McMahan RH, Abdelmalek MF, Rosen HR, Jackman MR, MacLean PS, Diggle CP, Asipu A, Inaba S, Kosugi T, et al. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology (Baltimore, Md.). 58: 1632-43. PMID 23813872 DOI: 10.1002/Hep.26594  0.305
2013 Yanagisawa K, Yue S, van der Vliet HJ, Wang R, Alatrakchi N, Golden-Mason L, Schuppan D, Koziel MJ, Rosen HR, Exley MA. Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C. Journal of Viral Hepatitis. 20: 556-65. PMID 23808994 DOI: 10.1111/Jvh.12081  0.541
2013 Brownell J, Wagoner J, Lovelace ES, Thirstrup D, Mohar I, Smith W, Giugliano S, Li K, Crispe IN, Rosen HR, Polyak SJ. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes. Journal of Hepatology. 59: 701-8. PMID 23770038 DOI: 10.1016/J.Jhep.2013.06.001  0.519
2013 Stone AE, Giugliano S, Schnell G, Cheng L, Leahy KF, Golden-Mason L, Gale M, Rosen HR. Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells. Plos Pathogens. 9: e1003316. PMID 23637605 DOI: 10.1371/Journal.Ppat.1003316  0.776
2013 McMahan RH, Wang XX, Cheng LL, Krisko T, Smith M, El Kasmi K, Pruzanski M, Adorini L, Golden-Mason L, Levi M, Rosen HR. Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease. The Journal of Biological Chemistry. 288: 11761-70. PMID 23460643 DOI: 10.1074/Jbc.M112.446575  0.373
2013 Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, ... ... Rosen HR, et al. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Annals of Internal Medicine. 158: 235-45. PMID 23420232 DOI: 10.7326/0003-4819-158-4-201302190-00003  0.483
2013 Golden-Mason L, McMahan RH, Strong M, Reisdorph R, Mahaffey S, Palmer BE, Cheng L, Kulesza C, Hirashima M, Niki T, Rosen HR. Galectin-9 functionally impairs natural killer cells in humans and mice. Journal of Virology. 87: 4835-45. PMID 23408620 DOI: 10.1128/Jvi.01085-12  0.456
2013 Biggins SW, Trotter J, Gralla J, Burton JR, Bambha KM, Dodge J, Brocato M, Cheng L, McQueen M, Forman L, Chang M, Kam I, Everson G, Spritz RA, Klintmalm G, ... Rosen HR, et al. Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation. Journal of Hepatology. 58: 969-76. PMID 23333445 DOI: 10.1016/J.Jhep.2012.12.027  0.479
2013 Lee HC, Sung SS, Krueger PD, Jo YA, Rosen HR, Ziegler SF, Hahn YS. Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes. Hepatology (Baltimore, Md.). 57: 1314-24. PMID 23150092 DOI: 10.1002/Hep.26128  0.588
2012 Biggins SW, Bambha KM, Terrault NA, Inadomi J, Shiboski S, Dodge JL, Gralla J, Rosen HR, Roberts JP. Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 18: 1471-8. PMID 23008049 DOI: 10.1002/Lt.23551  0.566
2012 Barjon C, Niki T, Vérillaud B, Opolon P, Bedossa P, Hirashima M, Blanchin S, Wassef M, Rosen HR, Jimenez AS, Wei M, Busson P. A novel monoclonal antibody for detection of galectin-9 in tissue sections: application to human tissues infected by oncogenic viruses. Infectious Agents and Cancer. 7: 16. PMID 22805533 DOI: 10.1186/1750-9378-7-16  0.398
2012 Golden-Mason L, Stone AE, Bambha KM, Cheng L, Rosen HR. Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity. Hepatology (Baltimore, Md.). 56: 1214-22. PMID 22505144 DOI: 10.1002/Hep.25771  0.783
2012 Foster RG, Golden-Mason L, Rutebemberwa A, Rosen HR. Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection. Digestive Diseases and Sciences. 57: 381-9. PMID 22183819 DOI: 10.1007/S10620-011-1997-Z  0.428
2012 Rutebemberwa A, Rosen HR. Of mice and men, calcineurin inhibitors and hepatitis C. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 18: 1-4. PMID 22034173 DOI: 10.1002/Lt.22458  0.382
2012 Tacke RS, Lee HC, Goh C, Courtney J, Polyak SJ, Rosen HR, Hahn YS. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology (Baltimore, Md.). 55: 343-53. PMID 21953144 DOI: 10.1002/Hep.24700  0.551
2011 Golden-Mason L, Bambha KM, Cheng L, Howell CD, Taylor MW, Clark PJ, Afdhal N, Rosen HR. Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C. Hepatology (Baltimore, Md.). 54: 1559-69. PMID 21983945 DOI: 10.1002/Hep.24556  0.469
2011 Rosen HR. Clinical practice. Chronic hepatitis C infection. The New England Journal of Medicine. 364: 2429-38. PMID 21696309 DOI: 10.1056/Nejmcp1006613  0.464
2011 Yang L, Rudser KD, Higgins L, Rosen HR, Zaman A, Corless CL, David L, Gourley GR. Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics. Digestive Diseases and Sciences. 56: 3305-15. PMID 21590334 DOI: 10.1007/S10620-011-1745-4  0.481
2011 Li H, Hughes AL, Bano N, McArdle S, Livingston S, Deubner H, McMahon BJ, Townshend-Bulson L, McMahan R, Rosen HR, Gretch DR. Genetic diversity of near genome-wide hepatitis C virus sequences during chronic infection: evidence for protein structural conservation over time. Plos One. 6: e19562. PMID 21573177 DOI: 10.1371/Journal.Pone.0019562  0.538
2011 Benson AB, Burton JR, Austin GL, Biggins SW, Zimmerman MA, Kam I, Mandell S, Silliman CC, Rosen H, Moss M. Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 17: 149-58. PMID 21280188 DOI: 10.1002/Lt.22212  0.371
2011 Kuntzen T, Neumann-Haefelin C, Lennon N, Talal A, Carlson J, Brumme C, Timm J, Schmidt J, Wunsch K, Berical A, Berlin A, Adams S, Young S, Reyor L, Kleyman M, ... ... Rosen H, et al. 3 POPULATIONAL ANALYSIS REVEALS A LINK BETWEEN COMPLEX VIRAL ESCAPE FROM CD8+ T-CELL RESPONSES AND PROTECTION IN HCV INFECTION Journal of Hepatology. 54: S2. DOI: 10.1016/S0168-8278(11)60005-6  0.475
2011 Li S, Popov Y, Cheng L, Rosen HR, Schuppan D. Galectin-9 Exhibits Proapoptotic and Antifbrotic Effects on Hepatic Stellate Cells Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)64064-X  0.497
2010 McMahan RH, Golden-Mason L, Nishimura MI, McMahon BJ, Kemper M, Allen TM, Gretch DR, Rosen HR. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. The Journal of Clinical Investigation. 120: 4546-57. PMID 21084749 DOI: 10.1172/Jci43127  0.53
2010 Hurtado CW, Golden-Mason L, Brocato M, Krull M, Narkewicz MR, Rosen HR. Innate immune function in placenta and cord blood of hepatitis C--seropositive mother-infant dyads. Plos One. 5: e12232. PMID 20814429 DOI: 10.1371/Journal.Pone.0012232  0.5
2010 Golden-Mason L, Cox AL, Randall JA, Cheng L, Rosen HR. Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro. Hepatology (Baltimore, Md.). 52: 1581-9. PMID 20812318 DOI: 10.1002/Hep.23896  0.505
2010 Zhang Y, Liu Y, Moxley KM, Golden-Mason L, Hughes MG, Liu T, Heemskerk MH, Rosen HR, Nishimura MI. Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity. Plos Pathogens. 6: e1001018. PMID 20686664 DOI: 10.1371/Journal.Ppat.1001018  0.553
2010 Mosbruger TL, Duggal P, Goedert JJ, Kirk GD, Hoots WK, Tobler LH, Busch M, Peters MG, Rosen HR, Thomas DL, Thio CL. Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus. The Journal of Infectious Diseases. 201: 1371-80. PMID 20331378 DOI: 10.1086/651606  0.493
2010 Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, McWilliams R, Randall JA, McMahan R, Zimmerman MA, Rangachari M, Dobrinskikh E, Busson P, Polyak SJ, Hirashima M, Rosen HR. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. Plos One. 5: e9504. PMID 20209097 DOI: 10.1371/Journal.Pone.0009504  0.589
2010 Tang X, Wagoner J, Negash A, Austin M, McLauchlan J, Hahn YS, Rosen HR, Polyak SJ. Functional characterization of core genes from patients with acute hepatitis C virus infection. The Journal of Infectious Diseases. 201: 912-22. PMID 20170366 DOI: 10.1086/650699  0.571
2010 Neumann-Haefelin C, Timm J, Schmidt J, Kersting N, Fitzmaurice K, Oniangue-Ndza C, Kemper MN, Humphreys I, McKiernan S, Kelleher D, Lohmann V, Bowness P, Huzly D, Rosen HR, Kim AY, et al. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope. Hepatology (Baltimore, Md.). 51: 54-62. PMID 20034048 DOI: 10.1002/Hep.23275  0.508
2010 McMahon BJ, Bruden D, Bruce MG, Livingston S, Christensen C, Homan C, Hennessy TW, Williams J, Sullivan D, Rosen HR, Gretch D. Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection. Gastroenterology. 138: 922-31.e1. PMID 19909749 DOI: 10.1053/J.Gastro.2009.10.056  0.532
2010 Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, McWilliams R, Randall JA, McMahan R, Zimmerman MA, Rangachari M, Dobrinskikh E, Busson P, Polyak SJ, Hirashima M, Rosen HR. Correction: A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection Plos One. 5. DOI: 10.1371/annotation/d15b793c-85c7-4529-bc80-aabcb088a8cf  0.352
2010 Fortune BE, Rosen HR, Burton JR. Management of HCV Infection and Liver Transplantation Evidence-Based Gastroenterology and Hepatology: Third Edition. 740-747. DOI: 10.1002/9781444314403.ch44  0.467
2009 Hughes MG, Rosen HR. Human liver transplantation as a model to study hepatitis C virus pathogenesis. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 15: 1395-411. PMID 19877210 DOI: 10.1002/Lt.21866  0.542
2009 Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 461: 798-801. PMID 19759533 DOI: 10.1038/Nature08463  0.571
2009 Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, McMahon BJ, Castelblanco N, Kuchroo V, Gretch DR, Rosen HR. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. Journal of Virology. 83: 9122-30. PMID 19587053 DOI: 10.1128/Jvi.00639-09  0.48
2009 Cummings KL, Rosen HR, Hahn YS. Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection. Clinical Immunology (Orlando, Fla.). 132: 401-11. PMID 19473882 DOI: 10.1016/J.Clim.2009.05.002  0.465
2009 Mengshol JA, Golden-Mason L, Castelblanco N, Im KA, Dillon SM, Wilson CC, Rosen HR. Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: Associations with antiviral treatment outcomes Gut. 58: 964-973. PMID 19193669 DOI: 10.1136/Gut.2008.168948  0.512
2009 Dazert E, Neumann-Haefelin C, Bressanelli S, Fitzmaurice K, Kort J, Timm J, McKiernan S, Kelleher D, Gruener N, Tavis JE, Rosen HR, Shaw J, Bowness P, Blum HE, Klenerman P, et al. Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. The Journal of Clinical Investigation. 119: 376-86. PMID 19139562 DOI: 10.1172/Jci36587  0.408
2009 Cox AL, Page K, Bruneau J, Shoukry NH, Lauer GM, Kim AY, Rosen HR, Radziewicz H, Grakoui A, Fierer DS, Branch AD, Kaplan DE, Chang KM. Rare birds in North America: acute hepatitis C cohorts. Gastroenterology. 136: 26-31. PMID 19059257 DOI: 10.1053/J.Gastro.2008.11.049  0.558
2009 Yee LJ, Im K, Wahed AS, Bugawan T, Li J, Rhodes SL, Erlich H, Rosen HR, Liang TJ, Yang H. Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C. Antimicrobial Agents and Chemotherapy. 53: 615-21. PMID 18852273 DOI: 10.1128/Aac.00947-08  0.455
2008 Kuntzen T, Timm J, Berical A, Lennon N, Berlin AM, Young SK, Lee B, Heckerman D, Carlson J, Reyor LL, Kleyman M, McMahon CM, Birch C, Schulze Zur Wiesch J, Ledlie T, ... ... Rosen HR, et al. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients. Hepatology (Baltimore, Md.). 48: 1769-78. PMID 19026009 DOI: 10.1002/Hep.22549  0.439
2008 Pandey JP, Namboodiri AM, Luo Y, Wu Y, Elston RC, Thomas DL, Rosen HR, Goedert JJ. Genetic markers of IgG influence the outcome of infection with hepatitis C virus. The Journal of Infectious Diseases. 198: 1334-6. PMID 18855559 DOI: 10.1086/592282  0.542
2008 Burton JR, Klarquist J, Im K, Smyk-Pearson S, Golden-Mason L, Castelblanco N, Terrault N, Rosen HR. Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy. Journal of Hepatology. 49: 329-38. PMID 18644644 DOI: 10.1016/J.Jhep.2008.05.020  0.461
2008 Su X, Yee LJ, Im K, Rhodes SL, Tang Y, Tong X, Howell C, Ramcharran D, Rosen HR, Taylor MW, Liang TJ, Yang H. Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C. Journal of Hepatology. 49: 184-91. PMID 18571276 DOI: 10.1016/J.Jhep.2008.04.011  0.45
2008 Rosen HR. Transplantation immunology: what the clinician needs to know for immunotherapy. Gastroenterology. 134: 1789-801. PMID 18471555 DOI: 10.1053/J.Gastro.2008.02.062  0.436
2008 Rhodes SL, Erlich H, Im KA, Wang J, Li J, Bugawan T, Jeffers L, Tong X, Su X, Rosen HR, Yee LJ, Liang TJ, Yang H. Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection. Genes and Immunity. 9: 328-33. PMID 18418397 DOI: 10.1038/gene.2008.21  0.412
2008 Golden-Mason L, Klarquist J, Wahed AS, Rosen HR. Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences. Journal of Immunology (Baltimore, Md. : 1950). 180: 3637-41. PMID 18322167 DOI: 10.4049/Jimmunol.180.6.3637  0.528
2008 Smyk-Pearson S, Golden-Mason L, Klarquist J, Burton JR, Tester IA, Wang CC, Culbertson N, Vandenbark AA, Rosen HR. Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection. The Journal of Infectious Diseases. 197: 46-57. PMID 18171284 DOI: 10.1086/523651  0.52
2008 Rosen HR, Doherty DG, Madrigal-Estebas L, O'Farrelly C, Golden-Mason L. Pretransplantation CD56(+) innate lymphocyte populations associated with severity of hepatitis C virus recurrence. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 14: 31-40. PMID 18161829 DOI: 10.1002/Lt.21265  0.589
2008 Smyk-Pearson S, Tester IA, Klarquist J, Palmer BE, Pawlotsky JM, Golden-Mason L, Rosen HR. Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help. Journal of Virology. 82: 1827-37. PMID 18045940 DOI: 10.1128/Jvi.01581-07  0.56
2008 Mengshol JA, Golden-Mason L, Castelblanco N, Im K, Rosen HR. 461 Combination Antiviral Therapy Differentially Affects Dendritic Cell Chemokine Receptor and Maturation Marker Expression in Chronic Hepatitis C Infection Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)63575-1  0.452
2008 Yee LJ, Im K, Wahed AS, Bugawan T, Li J, Rhodes SL, Erlich H, Rosen HR, Liang TJ, Yang H. 165 Polymorphism in the Human MHC and the Early Viral Decline During Treatment of HCV Gastroenterology. 134: A-756. DOI: 10.1016/S0016-5085(08)63530-1  0.482
2007 Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott EP, Shaw-Stiffel T, Weston SJ, Thiede H, Wald A, Rosen HR. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. The Journal of Infectious Diseases. 196: 1474-82. PMID 18008226 DOI: 10.1086/522608  0.53
2007 Mengshol JA, Golden-Mason L, Rosen HR. Mechanisms of Disease: HCV-induced liver injury. Nature Clinical Practice. Gastroenterology & Hepatology. 4: 622-34. PMID 17978819 DOI: 10.1038/Ncpgasthep0961  0.603
2007 Rosen HR. Liver retransplantation for hepatitis C: seeing is believing. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 13: 1217-8. PMID 17763404 DOI: 10.1002/Lt.21191  0.488
2007 Rosen HR, Weston SJ, Im K, Yang H, Burton JR, Erlich H, Klarquist J, Belle SH. Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy. Hepatology (Baltimore, Md.). 46: 350-8. PMID 17659573 DOI: 10.1002/Hep.21714  0.582
2007 Arjal RR, Burton JR, Villamil F, Rosen HR. Review article: the treatment of hepatitis C virus recurrence after liver transplantation. Alimentary Pharmacology & Therapeutics. 26: 127-140. PMID 17593060 DOI: 10.1111/J.1365-2036.2007.03364.X  0.497
2007 Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N, Rosen HR. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. Journal of Virology. 81: 9249-58. PMID 17567698 DOI: 10.1128/Jvi.00409-07  0.506
2007 Golden-Mason L, Castelblanco N, O'Farrelly C, Rosen HR. Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection. Journal of Virology. 81: 9292-8. PMID 17553896 DOI: 10.1128/Jvi.00834-07  0.568
2007 Wertheimer AM, Polyak SJ, Leistikow R, Rosen HR. Engulfment of apoptotic cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells. Hepatology (Baltimore, Md.). 45: 1422-32. PMID 17538964 DOI: 10.1002/Hep.21637  0.5
2007 Zaman A, Rosen HR, Ingram K, Corless CL, Oh E, Smith K. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients. The American Journal of Medicine. 120: 280.e9-14. PMID 17349453 DOI: 10.1016/J.Amjmed.2006.06.044  0.473
2007 Huang Y, Yang H, Borg BB, Su X, Rhodes SL, Yang K, Tong X, Tang G, Howell CD, Rosen HR, Thio CL, Thomas DL, Alter HJ, Sapp RK, Liang TJ. A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection. Proceedings of the National Academy of Sciences of the United States of America. 104: 985-90. PMID 17215375 DOI: 10.1073/Pnas.0609954104  0.532
2007 Rosen HR, Friedman LS, Martin P. Hepatitis C and the Renal Transplant Patient Seminars in Dialysis. 9: 39-46. DOI: 10.1111/j.1525-139X.1996.tb00899.x  0.307
2007 Huang Y, Yang H, Borg BB, Su X, Rhodes SL, Yang K, Tong X, Tang G, Howell CD, Rosen HR, Thio CL, Thomas DL, Alter HJ, Sapp RK, Liang TJ. Erratum: A functional SNP of interferon-γ gene is important for interferon-α-induced and spontaneous recovery from hepatitis C virus infection (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, (985-990) DOI: 10.1073/pnas.0609954104) Proceedings of the National Academy of Sciences of the United States of America. 104. DOI: 10.1073/Pnas.0701153104  0.427
2007 Gopal DV, Rosen HR. Reply to: Sustained resolutin of fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy Liver Transplantation. 13: 312-312. DOI: 10.1002/Lt.21055  0.482
2006 Golden-Mason L, Burton JR, Castelblanco N, Klarquist J, Benlloch S, Wang C, Rosen HR. Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology (Baltimore, Md.). 44: 1098-109. PMID 17058243 DOI: 10.1002/Hep.21365  0.42
2006 Burton JR, Rosen HR. Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 12: S38-47. PMID 17051562 DOI: 10.1002/Lt.20944  0.575
2006 Burton JR, Rosen HR. Diagnosis and management of allograft failure. Clinics in Liver Disease. 10: 407-35, x. PMID 16971269 DOI: 10.1016/J.Cld.2006.05.003  0.306
2006 Van Kleek EJ, Schwartz JM, Rayhill SC, Rosen HR, Cotler SJ. Liver transplantation for hepatocellular carcinoma: a survey of practices. Journal of Clinical Gastroenterology. 40: 643-7. PMID 16917411 DOI: 10.1097/00004836-200608000-00018  0.331
2006 Smyk-Pearson S, Tester IA, Lezotte D, Sasaki AW, Lewinsohn DM, Rosen HR. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design. The Journal of Infectious Diseases. 194: 454-63. PMID 16845628 DOI: 10.1086/505714  0.522
2006 Burton JR, Rosen HR. Treatment of HCV recurrence: do the pretransplantation rules apply? Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 12: 1044-8. PMID 16799952 DOI: 10.1002/Lt.20783  0.472
2006 Callender GG, Rosen HR, Roszkowski JJ, Lyons GE, Li M, Moore T, Brasic N, McKee MD, Nishimura MI. Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition. Hepatology (Baltimore, Md.). 43: 973-81. PMID 16628627 DOI: 10.1002/Hep.21157  0.572
2006 Golden-Mason L, Rosen HR. Natural killer cells: primary target for hepatitis C virus immune evasion strategies? Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 12: 363-72. PMID 16498647 DOI: 10.1002/Lt.20708  0.585
2005 Burton JR, Rosen HR. Liver retransplantation for hepatitis C virus recurrence: a survey of liver transplant programs in the United States. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 3: 700-4. PMID 16206504 DOI: 10.1016/S1542-3565(05)00158-8  0.511
2005 Tester I, Smyk-Pearson S, Wang P, Wertheimer A, Yao E, Lewinsohn DM, Tavis JE, Rosen HR. Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. The Journal of Experimental Medicine. 201: 1725-31. PMID 15939788 DOI: 10.1084/Jem.20042284  0.552
2005 Martinez OM, Rosen HR. Basic concepts in transplant immunology. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 11: 370-81. PMID 15776458 DOI: 10.1002/Lt.20406  0.302
2005 Weston SJ, Leistikow RL, Reddy KR, Torres M, Wertheimer AM, Lewinsohn DM, Chou S, Davey MP, Corless C, O'Farrelly C, Nelson DR, Rosen HR. Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation. Hepatology (Baltimore, Md.). 41: 72-81. PMID 15619226 DOI: 10.1002/Hep.20507  0.603
2004 Burton JR, Rosen HR. Retransplantation for hepatitis C: what do we really know? Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 10: 1504-6. PMID 15558586 DOI: 10.1002/Lt.20325  0.486
2004 Rosen HR, Hinrichs DJ, Leistikow RL, Callender G, Wertheimer AM, Nishimura MI, Lewinsohn DM. Cutting edge: identification of hepatitis C virus-specific CD8+ T cells restricted by donor HLA alleles following liver transplantation. Journal of Immunology (Baltimore, Md. : 1950). 173: 5355-9. PMID 15494481 DOI: 10.4049/Jimmunol.173.9.5355  0.503
2004 Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, Nelson DR. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology (Baltimore, Md.). 40: 1062-71. PMID 15486925 DOI: 10.1002/Hep.20454  0.368
2004 Burton JR, Sonnenberg A, Rosen HR. Retransplantation for recurrent hepatitis C in the MELD era: maximizing utility. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 10: S59-64. PMID 15382221 DOI: 10.1002/Lt.20259  0.563
2004 Wertheimer AM, Bakke A, Rosen HR. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology (Baltimore, Md.). 40: 335-45. PMID 15368438 DOI: 10.1002/Hep.20306  0.553
2004 Brown RS, Rush SH, Rosen HR, Langnas AN, Klintmalm GB, Hanto DW, Punch JD. Liver and intestine transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 4: 81-92. PMID 15113357 DOI: 10.1111/J.1600-6135.2004.00400.X  0.36
2004 Austin GL, Sasaki AW, Zaman A, Rabkin JM, Olyaei A, Ruimy R, Orloff SL, Ham J, Rosen HR. Comparative analysis of outcome following liver transplantation in US veterans. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 4: 788-95. PMID 15084176 DOI: 10.1111/J.1600-6143.2004.00388.X  0.353
2004 Chan SE, Schwartz JM, Rosen HR. Treatment of hepatitis C in solid organ transplantation. Drugs. 64: 489-98. PMID 14977386 DOI: 10.2165/00003495-200464050-00003  0.534
2004 Zaman A, Rosen H, Oh E, Ingram K, Smith K. PROSPECTIVE ASSESSMENT OF FIBROSpect II HEPATIC TO DETECT FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C: 241 The American Journal of Gastroenterology. 99. DOI: 10.14309/00000434-200410001-00240  0.48
2004 Soule JL, Olyaei AJ, Schwartz JM, Rosen HR, Ham JM, Orloff SL. HEPATITIS C RECURRENCE IS A SURROGATE MARKER FOR POOR OUTCOME FOLLOWING LIVER RETRANSPLANTATION Transplantation. 78: 395. DOI: 10.1097/00007890-200407271-01058  0.34
2004 Golden-Mason L, Kelly A, Rosen H, Hegarty J, O'Farrelly C, Long A. HCV:CD81 Interactions Inhibit Il-2 Production by T Cells: A Novel HCV Immune Evasion Strategy Endoscopy. 36. DOI: 10.1055/S-2004-834507  0.388
2003 Rosen HR. Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 9: S35-43. PMID 14586893 DOI: 10.1053/Jlts.2003.50253  0.589
2003 Simon BE, Cornell KA, Clark TR, Chou S, Rosen HR, Barry RA. DNA vaccination protects mice against challenge with Listeria monocytogenes expressing the hepatitis C virus NS3 protein. Infection and Immunity. 71: 6372-80. PMID 14573658 DOI: 10.1128/Iai.71.11.6372-6380.2003  0.469
2003 Gopal DV, Corless CL, Rabkin JM, Olyaei AJ, Rosen HR. Graft failure from severe recurrent primary sclerosing cholangitis following orthotopic liver transplantation. Journal of Clinical Gastroenterology. 37: 344-7. PMID 14506394 DOI: 10.1097/00004836-200310000-00015  0.426
2003 Chan SE, Rosen HR. Outcome and management of hepatitis C in liver transplant recipients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 37: 807-12. PMID 12955642 DOI: 10.1086/377605  0.599
2003 Rosen HR. Hepatitis C virus in the human liver transplantation model. Clinics in Liver Disease. 7: 107-25. PMID 12691461 DOI: 10.1016/S1089-3261(02)00073-9  0.572
2003 Jazrawi SF, Zaman A, Muhammad Z, Rabkin JM, Corless CL, Olyaei A, Biggs A, Ham J, Chou S, Rosen HR. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 9: 377-82. PMID 12682890 DOI: 10.1053/Jlts.2003.50064  0.488
2003 Gopal DV, Rosen HR. Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 9: 348-53. PMID 12682884 DOI: 10.1053/Jlts.2003.50062  0.55
2003 Wertheimer AM, Miner C, Lewinsohn DM, Sasaki AW, Kaufman E, Rosen HR. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology (Baltimore, Md.). 37: 577-89. PMID 12601356 DOI: 10.1053/Jhep.2003.50115  0.468
2003 Rosen HR, Pawlotsky J. Scientific advances in hepatitis C virus Clinics in Liver Disease. 7. DOI: 10.1016/S1089-3261(02)00070-3  0.568
2003 Golden-Mason LM, Asrafel H, Rosen H, Madrigal-Estebas L, Doherty DG, Hegarty J. 616 Peripheral natural killer (NK) cells are depleted and functionally impaired in chronic HCV infection Hepatology. 38: 458-459. DOI: 10.1016/S0270-9139(03)80658-4  0.497
2003 Gourley GR, Yang L, David LL, Corless CL, Wertheimer AM, Rosen HR. 584 Proteomics to predict hepatitis C fibrosis Hepatology. 38: 442-443. DOI: 10.1016/S0270-9139(03)80626-2  0.44
2003 Tester IA, Smyk-Pearson S, Dean S, Rosen HR. 411 Acute hepatitis C infection following patellar tendon transplantation: immunologic correlates of recovery Hepatology. 38: 358-358. DOI: 10.1016/S0270-9139(03)80454-8  0.47
2003 WERTHEIMER A, LEISTIKOW R, ROSEN H. 387 Gene expression array, phenotypic, and functional assessment of human dendritic cells engulfing HCV-infected apoptotic cells Hepatology. 38: 346-346. DOI: 10.1016/S0270-9139(03)80430-5  0.463
2003 Smyk-Pearson S, Tester I, Sasaki AW, Rosen HR. 383 Comprehensive HCV genome-wide analysis of CD4+ and CD8+ T cells reveals hierarchy of immunodominance Hepatology. 38: 344-344. DOI: 10.1016/S0270-9139(03)80426-3  0.386
2003 Cabreara R, Tu Z, Firpi RJ, Xu Y, Rosen H, Nelson DR. An immunomodulatory role for CD4+ CD25+ T lymphocytes in hepatitis C infection Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)83586-2  0.367
2003 Wertheimer AM, Rosen HR. Immunity and persistence in hepatitis C virus infection Current Hepatitis Reports. 2: 152-158. DOI: 10.1007/S11901-003-0017-Y  0.479
2002 Rosen HR. Hepatitis C in the liver transplant recipient: current understanding and treatment. Microbes and Infection / Institut Pasteur. 4: 1253-8. PMID 12467767 DOI: 10.1016/S1286-4579(02)01653-2  0.611
2002 Rabkin JM, Rosen HR, Corless CL, Olyaei AJ. Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients. Transplantation Proceedings. 34: 1557-8. PMID 12176483 DOI: 10.1016/S0041-1345(02)03020-8  0.36
2002 Rosen HR, Marousek G, Chou S. A longitudinal analysis of T-cell epitope-coding regions of hepatitis C virus after liver transplantation. Transplantation. 74: 209-16. PMID 12151733 DOI: 10.1097/00007890-200207270-00011  0.607
2002 Rosen HR, Schwartz JM. Hepatitis C quasispecies and severity of recurrence: cause, consequence, or coincidence? Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 8: 646-8. PMID 12089722 DOI: 10.1053/Jlts.2002.0080646  0.574
2002 Rosen HR, Ribeiro RR, Weinberger L, Wolf S, Chung M, Gretch DR, Perelson AS. Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy Journal of Hepatology. 37: 124-130. PMID 12076871 DOI: 10.1016/S0168-8278(02)00114-9  0.424
2002 Murphy MD, Rosen HR, Marousek GI, Chou S. Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection. Digestive Diseases and Sciences. 47: 1195-205. PMID 12064791 DOI: 10.1023/A:1015349924116  0.509
2002 Rabkin JM, Corless CL, Rosen HR, Olyaei AJ. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. American Journal of Surgery. 183: 595-9. PMID 12034401 DOI: 10.1016/S0002-9610(02)00826-7  0.322
2002 Biggins SW, Beldecos A, Rabkin JM, Rosen HR. Retransplantation for hepatic allograft failure: prognostic modeling and ethical considerations. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 8: 313-22. PMID 11965573 DOI: 10.1053/Jlts.2002.31746  0.39
2002 Rosen HR, McHutchison JG, Conrad AJ, Lentz JJ, Marousek G, Rose SL, Zaman A, Taylor K, Chou S. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. The American Journal of Gastroenterology. 97: 714-20. PMID 11922568 DOI: 10.1111/j.1572-0241.2002.05552.x  0.442
2002 Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, Bakke A, Bouwer HG, Hinrichs DJ. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology (Baltimore, Md.). 35: 190-8. PMID 11786976 DOI: 10.1053/jhep.2002.30293  0.499
2002 Rosen HR, McHutchison JG, Conrad AJ, Lentz JJ, Marousek G, Rose SL, Zaman A, Taylor K, Chou S. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C The American Journal of Gastroenterology. 97: 714-720. DOI: 10.1016/S0002-9270(01)04114-4  0.406
2001 Rosen HR. Hepatitis B and C in the liver transplant recipient: current understanding and treatment. Liver Transplantation. 7. PMID 11689781 DOI: 10.1053/Jlts.2001.28519  0.61
2001 Davey MP, Rosen HR, Woody CN, Haley DP, Kurkinen J, Lewinsohn DM. T-cell clones derived by CD3 stimulation from hepatitis C virus explanted liver tissue are not representative of dominant clones present in vivo. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 7: 716-23. PMID 11510018 DOI: 10.1053/Jlts.2001.26058  0.439
2001 Rabkin JM, de La Melena V, Orloff SL, Corless CL, Rosen HR, Olyaei AJ. Late mortality after orthotopic liver transplantation. American Journal of Surgery. 181: 475-9. PMID 11448447 DOI: 10.1016/S0002-9610(01)00595-5  0.329
2001 Rabkin JM, Rosen HR, Corless CL, Orloff SL, Olyaei AJ. Prophylactic antiviral therapy in CMV high-risk liver transplant recipients. Transplantation Proceedings. 33: 1811-2. PMID 11267523 DOI: 10.1016/S0041-1345(00)02691-9  0.378
2001 Rabkin JM, Corless CL, Rosen HR, Olyaei AJ. Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation. Transplantation Proceedings. 33: 1532-4. PMID 11267411 DOI: 10.1016/S0041-1345(00)02585-9  0.364
2001 Gopal DV, Rabkin JM, Berk BS, Corless CL, Chou S, Olyaei A, Orloff SL, Rosen HR. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 7: 181-90. PMID 11244158 DOI: 10.1053/Jlts.2001.22447  0.563
2001 Powers JJ, Shumaker DA, Rosen HR. Liver transplantation for chronic hepatitis C: Long-term results, role of antiviral therapy, and outcome of retransplantation Current Opinion in Organ Transplantation. 6: 114-119. DOI: 10.1097/00075200-200106000-00003  0.526
2001 Rosen HR. Viral Hepatitis: A Handbook for Clinicians and Scientists. Elizabeth Ann Fagan , Tim J. Harrison The Quarterly Review of Biology. 76: 535-535. DOI: 10.1086/420659  0.409
2000 Rosen HR. Disease recurrence following liver transplantation. Clinics in Liver Disease. 4: 675-689. PMID 11232167 DOI: 10.1016/S1089-3261(05)70132-X  0.426
2000 Rosen HR, Martin P. Hepatitis B and C in the liver transplant recipient. Seminars in Liver Disease. 20: 465-480. PMID 11200416 DOI: 10.1055/S-2000-13156  0.593
2000 Gralnek IM, Hays RD, Kilbourne A, Rosen HR, Keeffe EB, Artinian L, Kim S, Lazarovici D, Jensen DM, Busuttil RW, Martin P. Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease--the LDQOL 1.0. The American Journal of Gastroenterology. 95: 3552-65. PMID 11151892 DOI: 10.1111/j.1572-0241.2000.03375.x  0.355
2000 Rosen HR. Retransplantation for hepatitis C: implications of different policies. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 6: S41-6. PMID 11084084 DOI: 10.1053/JLTS.2000.18689  0.513
2000 Faigel DO, Rosen HR, Sasaki A, Flora K, Benner K. EUS in cirrhotic patients with and without prior variceal hemorrhage in comparison with noncirrhotic control subjects. Gastrointestinal Endoscopy. 52: 455-462. PMID 11023560 DOI: 10.1067/Mge.2000.107297  0.303
2000 Rosen HR, Martin P. Viral hepatitis in the liver transplant recipient. Infectious Disease Clinics of North America. 14: 761-784. PMID 10987119 DOI: 10.1016/S0891-5520(05)70130-6  0.51
2000 Rosen HR, Gretch D, Kaufman E, Quan S. Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay The American Journal of Gastroenterology. 95: 2035-2039. PMID 10950054 DOI: 10.1111/J.1572-0241.2000.02264.X  0.494
2000 Rabkin JM, Oroloff SL, Corless CL, Benner KG, Flora KD, Rosen HR, Olyaei AJ. Association of fungal infection and increased mortality in liver transplant recipients. American Journal of Surgery. 179: 426-30. PMID 10930495 DOI: 10.1016/S0002-9610(00)00366-4  0.357
2000 Rosen HR. Primer on hepatitis C for hospital epidemiologists. Infection Control and Hospital Epidemiology. 21: 229-234. PMID 10738998 DOI: 10.1086/501752  0.548
2000 Gopal DV, Rosen HR. Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis. Postgraduate Medicine. 107: 100-114. PMID 10689411 DOI: 10.3810/Pgm.2000.02.869  0.38
2000 Rabkin JM, Orloff SL, Corless CL, Brown E, Rosen HR, Olyaei AJ. GANCICLOVIR DOES NOT INCREASE THE RISK OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION. Transplantation. 69: S319. DOI: 10.1097/00007890-200004271-00797  0.534
2000 Gopal D, Rabkin J, Berk B, Corless C, Olyaei A, Orloff S, Rosen HR. TREATMENT OF PROGRESSIVE HCV RECURRENCE POST LIVER TRANSPLANTATION WITH COMBINATION INTERFERON PLUS RIBAVIRIN.: Abstract# 770 Poster Board #-Session: P27-III Transplantation. 69. DOI: 10.1097/00007890-200004271-00770  0.542
2000 Rosen HR, Miner C, Bakke A, Bouwer A, Rabkin J, Hinrichs DJ. FLOW CYTOMETRIC ANALYSIS OF SPECIFIC INTRACELLULAR CYTOKINE (ICC) PRODUCTION FOLLOWING LIVER TRANSPLANTATION FOR HEPATITIS C.: Abstract# 600 Transplantation. 69. DOI: 10.1097/00007890-200004271-00600  0.464
2000 Gopal DV, Rabkin J, Berk BS, Corless CL, Olyaei A, Orloff SL, Rosen HR. Treatment of progenessive HCV recurrence post liver transplantation with combination interferon plus Ribavirin Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)86131-4  0.557
1999 Rosen HR, Lentz JJ, Rose SL, Rabkin J, Corless CL, Taylor K, Chou S. Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation. Transplantation. 68: 1898-902. PMID 10628771 DOI: 10.1097/00007890-199912270-00014  0.556
1999 Rosen HR, Chou S, Sasaki AW, Gretch DR. Molecular epidemiology of hepatitis C infection in U.S. veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B The American Journal of Gastroenterology. 94: 3015-3019. PMID 10520862 DOI: 10.1111/J.1572-0241.1999.01456.X  0.491
1999 Rosen HR, Hinrichs DJ, Gretch DR, Koziel MJ, Chou S, Houghton M, Rabkin J, Corless CL, Bouwer HG. Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology. 117: 926-32. PMID 10500076 DOI: 10.1016/S0016-5085(99)70352-5  0.588
1999 Rosen HR, Gretch DR. Hepatitis C virus: current understanding and prospects for future therapies Molecular Medicine Today. 5: 393-399. PMID 10462751 DOI: 10.1016/S1357-4310(99)01523-3  0.586
1999 Orloff SL, Busch AM, Olyaei AJ, Corless CL, Benner KG, Flora KD, Rosen HR, Rabkin JM. Vancomycin-resistant Enterococcus in liver transplant patients. American Journal of Surgery. 177: 418-22. PMID 10365883 DOI: 10.1016/S0002-9610(99)00083-5  0.38
1999 Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR, Yersiz H, Markmann JF, Drazan KE, Holt C, Imagawa D, Goldstein LI, Martin P, Busuttil RW. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience. Annals of Surgery. 229: 824-31; discussion 8. PMID 10363896 DOI: 10.1097/00000658-199906000-00009  0.457
1999 Barkhuizen A, Rosen HR, Wolf S, Flora K, Benner K, Bennett RM. Musculoskeletal pain and fatigue are associated with chronic hepatitis C The American Journal of Gastroenterology. 94: 1355-1360. PMID 10235218 DOI: 10.1111/J.1572-0241.1999.01087.X  0.352
1999 Rosen HR, Madden JP, Martin P. A model to predict survival following liver retransplantation. Hepatology (Baltimore, Md.). 29: 365-70. PMID 9918911 DOI: 10.1002/Hep.510290221  0.385
1999 Ghobrial RM, Farmer DG, Holt C, Rosen H, Yersiz H, Baquerizo A, Drazan KE, Chen P, Dawsom S, Romani L, Melinek J, Imagawa D, Seu P, Goldstein LI, Martin P, et al. TACROLIMUS VERSUS CYCLOSPORINE IMMUNOSUPPRESSION IN LIVER TRANSPLANTATION FOR HEPATITIS C Transplantation. 67: S587. DOI: 10.1097/00007890-199905150-00201  0.376
1999 Rosen HR, Lenz J, Rose S, Rabkin J, Corless CL, Chou S. DONOR POLYMORPHISM OF TUMOR NECROSIS FACTOR (TNF) GENES ASSOCIATED WITH VARIABLE SEVERITY OF HEPATITIS C (HCV) RECURRENCE FOLLOWING LIVER TRANSPLANTATION Transplantation. 67: S15. DOI: 10.1097/00007890-199904150-00061  0.444
1999 Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease The American Journal of Gastroenterology. 94: 3292-3296. DOI: 10.1016/S0002-9270(99)00599-7  0.307
1999 Barkhuizen A, Rosen HR, Wolf S, Flora K, Benner K, Bennett RM. Musculoskeletal pain and fatigue are associated with chronic hepatitis C: A report of 239 hepatology clinic patients The American Journal of Gastroenterology. 94: 1355-1360. DOI: 10.1016/S0002-9270(99)00143-4  0.455
1999 Zaman A, Hapke R, Flora K, Rosen H, Benner K. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. The American Journal of Gastroenterology. 94: 895-899. DOI: 10.1016/S0002-9270(99)00039-8  0.336
1998 Rosen HR. Liver Disease Associated With Alpha1-Antitrypsin Deficiency Clinics in Liver Disease. 2: 175-185. PMID 15560052 DOI: 10.1016/S1089-3261(05)70370-6  0.348
1998 Rosen HR, Corless CL, Rabkin J, Chou S. Association of cytomegalovirus genotype with graft rejection after liver transplantation. Transplantation. 66: 1627-31. PMID 9884250 DOI: 10.1097/00007890-199812270-00010  0.4
1998 Rosen HR, Martin P. Hepatitis C infection in patients undergoing liver retransplantation Transplantation. 66: 1612-1616. PMID 9884247 DOI: 10.1097/00007890-199812270-00007  0.567
1998 Ghobrial RM, Colquhoun S, Rosen H, Hollis P, Ponthieux S, Pakrasi A, Farmer DG, Markman JF, Markowitz J, Drazan K, Yersiz H, Singer J, Stribling R, Arnout W, Holt CD, et al. Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression. Transplantation Proceedings. 30: 1470-1. PMID 9636597 DOI: 10.1016/S0041-1345(98)00320-0  0.383
1998 Rabkin JM, Corless CL, Orloff SL, Benner KG, Flora KD, Rosen HR, Olyaei AJ. Liver transplantation for disulfiram-induced hepatic failure. The American Journal of Gastroenterology. 93: 830-1. PMID 9625138 DOI: 10.1111/J.1572-0241.1998.235_A.X  0.48
1998 Rosen HR, Gretch DR, Oehlke M, Flora KD, Benner KG, Rabkin JM, Corless CL. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation. 65: 1178-82. PMID 9603164 DOI: 10.1097/00007890-199805150-00006  0.574
1998 Rabkin JM, Orloff SL, Corless CL, Benner KG, Flora KD, Rosen HR, Keller FS, Barton RE, Lakin PC, Petersen BD, Saxon RR, Olyaei AJ. Hepatic allograft abscess with hepatic arterial thrombosis. American Journal of Surgery. 175: 354-9. PMID 9600276 DOI: 10.1016/S0002-9610(98)00051-8  0.466
1998 Flora K, Hahn M, Rosen H, Benner K. Milk Thistle ( Silybum marianum ) for the Therapy of Liver Disease The American Journal of Gastroenterology. 93: 139-143. PMID 9468229 DOI: 10.1111/J.1572-0241.1998.00139.X  0.36
1998 Rabkin JM, Orloff SL, Corless CL, Benner KG, Flora KD, Rosen HR, Olyaei AJ. Natural History Of Hepatitis C Recurrence In Orthotopic Liver Transplant Recipients For Hepatitis C Alone Vs Hepatitis C And Alcoholic Cirrhosis Transplantation. 66. DOI: 10.1097/00007890-199810270-00232  0.503
1998 Rosen HR, Martin P. HEPATITIS C INFECTION IN PATIENTS UNDERGOING HEPATIC RETRANSPLANTATION(ReTx) Transplantation. 65: S105. DOI: 10.1097/00007890-199806270-00430  0.45
1998 Rosen HR, Martin P. HEPATITIS C INFECTION IN PATIENTS UNDERGOING HEPATIC RETRANSPLANTION(ReTx). Transplantation. 65: 181. DOI: 10.1097/00007890-199805131-00409  0.45
1998 Rabkin JM, Orloff SL, Corless CL, Benner KG, Flora KD, Rosen HR, Olyaei AJ. Short term safety and efficacy of famciclovir in prevention of CMV infection in liver transplant recipients Gastroenterology. 114. DOI: 10.1016/S0016-5085(98)85378-X  0.358
1998 Faigel D, Rosen H, Sasaki A, Flora K, Benner K. Endoscopic ultrasound in cirrhosis: Prevalence of findings in comparison with healthy controls Gastroenterology. 114. DOI: 10.1016/S0016-5085(98)85026-9  0.344
1998 Hahn M, Rosen HR. Diseases of the Gastrointerstinal Tract and Liver Gastroenterology. 114: 615-616. DOI: 10.1016/S0016-5085(98)70554-2  0.36
1998 Flora K, Hahn M, Rosen H, Benner K. Clinical reviewMilk thistle (Silybum marianum) for the therapy of liver disease The American Journal of Gastroenterology. 93. DOI: 10.1016/S0002-9270(97)00082-8  0.336
1997 Rosen HR, Martin P, Schiller GJ, Territo M, Lewin DN, Shackleton CR, Busuttil RW. Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver. Liver Transplantation and Surgery : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 2: 225-32. PMID 9346652 DOI: 10.1002/LT.500020308  0.345
1997 Rosen HR, Chou S, Corless CL, Gretch DR, Flora KD, Boudousquie A, Orloff SL, Rabkin JM, Benner KG. Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation. 64: 721-6. PMID 9311709 DOI: 10.1097/00007890-199709150-00010  0.578
1997 Rosen HR. Acquisition of hepatitis C by a conjunctival splash American Journal of Infection Control. 25: 242-247. PMID 9202821 DOI: 10.1016/S0196-6553(97)90011-0  0.482
1997 O'Reilly PM, Rosen HR, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P. Causes of graft loss following liver transplantation for chronic hepatitis C. Transplantation Proceedings. 29: 526-8. PMID 9123116 DOI: 10.1016/S0041-1345(96)00254-0  0.363
1997 Rosen HR, Benner KG, Flora KD, Rabkin JM, Orloff SL, Olyaei A, Chou S. Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation. Transplantation. 63: 476-8. PMID 9039944 DOI: 10.1097/00007890-199702150-00026  0.387
1997 Rosen HR, Martin P. Okt3 And Hepatitis C : Defining The Risks Transplantation. 63: 171-172. PMID 9000685 DOI: 10.1097/00007890-199701150-00035  0.429
1997 Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation. 62: 1773-6. PMID 8990361 DOI: 10.1097/00007890-199612270-00015  0.481
1996 Rosen HR, Shackleton CR, Martin P. Indications For And Timing Of Liver Transplantation Medical Clinics of North America. 80: 1069-1102. PMID 8804375 DOI: 10.1016/S0025-7125(05)70480-6  0.411
1994 Hoffman AL, Rosen HR, Ljubimova JU, Sher L, Podesta LG, Demetriou AA, Makowka L. Hepatic regeneration: current concepts and clinical implications. Seminars in Liver Disease. 14: 190-210. PMID 8047902 DOI: 10.1055/S-2007-1007311  0.389
Show low-probability matches.